Chronic disease cited as reason for increase in drug expenditures
MANAGED CARE August 2002. ©MediMedia USA
Retail prescription drug sales, in terms of dollars, rose 17.3 percent in 2001, though increases varied widely from state to state. An audit by Verispan Scott-Levin shows that increases in drug expenditures ranged from 12 percent in Maine to 25 percent in Alaska. Verispan Scott-Levin collects information from over 140 million prescription claims monthly, covering 71 percent of retail dispensing activity nationwide. Verispan is a new joint venture of Quintiles Transnational Corp. (which included Scott-Levin) and McKesson Corp.
Increase in expenditures, by state
SOURCE: VERISPAN SCOTT-LEVIN, SOURCE PRESCRIPTION AUDIT, 2001